Company · founded 1965

Charles River Associates

Boston, United States · charlesriverassociates.com

Manage this page

Citations, last 5 years: 680
Works, last 5 years: 184
h-index: 83
Scientists listed: 13
Grants since 2016: 1 402

Grants received

2009–2021 · research · R01

Interdisciplinary Study of Two Novel Anticonvulsants in Alcoholism

David H. Barlow · Charles River Associates · funded by National Institutes of Health

$769k

2009–2021 · research · R01

Interdisciplinary Study of Two Novel Anticonvulsants in Alcoholism

David H. Barlow · Charles River Associates · funded by National Institutes of Health

$764.1k

2009–2025 · research · R01

Illuminating Dynamic Receptor Clustering in the Epidermal Growth Factor Receptor Signal Transduction Pathway Using Plasmon Coupling

Bjoern Markus Reinhard · Charles River Associates · funded by National Institutes of Health

$384kHER2/EGFR in Cancer Research

2009–2025 · research · R01

Illuminating Dynamic Receptor Clustering in the Epidermal Growth Factor Receptor Signal Transduction Pathway Using Plasmon Coupling

Bjoern Markus Reinhard · Charles River Associates · funded by National Institutes of Health

$376.4kHER2/EGFR in Cancer Research

2009–2027 · training · T32

Translational Research in Biomaterials

Mark W. Grinstaff · Charles River Associates · funded by National Institutes of Health

$223.7kBiomedical and Engineering Education

2009–2020 · research · R01

Neurobehavioral Research on Infants at Risk for Language Delay and ASD

Charles Alexander Nelson · Charles River Associates · funded by National Institutes of Health

$596.5k

2009–2020 · research · R01

Neurobehavioral Research on Infants at Risk for Language Delay and ASD

Charles Alexander Nelson · Charles River Associates · funded by National Institutes of Health

$740.1k

2009–2025 · research · R01

Illuminating Dynamic Receptor Clustering in the Epidermal Growth Factor Receptor Signal Transduction Pathway Using Plasmon Coupling

Bjoern Markus Reinhard · Charles River Associates · funded by National Institutes of Health

$72.2kHER2/EGFR in Cancer Research

2009–2025 · research · R01

Illuminating Dynamic Receptor Clustering in the Epidermal Growth Factor Receptor Signal Transduction Pathway Using Plasmon Coupling

Bjoern Markus Reinhard · Charles River Associates · funded by National Institutes of Health

$391.9kHER2/EGFR in Cancer Research

2009–2027 · training · T32

Translational Research in Biomaterials

Mark W. Grinstaff · Charles River Associates · funded by National Institutes of Health

$305.5kBiomedical and Engineering Education

2009–2020 · training · T32

Translational Research in Biomaterials

Mark W. Grinstaff · Charles River Associates · funded by National Institutes of Health

$261.9kBiomedical and Engineering Education

2009–2027 · training · T32

Translational Research in Biomaterials

Mark W. Grinstaff · Charles River Associates · funded by National Institutes of Health

$318.4kBiomedical and Engineering Education

2009–2027 · training · T32

Translational Research in Biomaterials

Mark W. Grinstaff · Charles River Associates · funded by National Institutes of Health

$252.7k

2008–2024 · research · R01

3-D Visualization and Prediction of Vertebral Fractures

Elise F Morgan · Charles River Associates · funded by National Institutes of Health

$555.5kMedical Imaging and Analysis

2008–2024 · research · R01

3-D Visualization and Prediction of Vertebral Fractures

Elise F Morgan · Charles River Associates · funded by National Institutes of Health

$626.6kMedical Imaging and Analysis

2008–2025 · research · R01

3-D Visualization and Prediction of Vertebral Fractures

Elise F Morgan · Charles River Associates · funded by National Institutes of Health

$52.5kMedical Imaging and Analysis

2008–2024 · research · R01

3-D Visualization and Prediction of Vertebral Fractures

Elise F Morgan · Charles River Associates · funded by National Institutes of Health

$680.7kMedical Imaging and Analysis

2008–2025 · research · R01

3-D Visualization and Prediction of Vertebral Fractures

Elise F Morgan · Charles River Associates · funded by National Institutes of Health

$539.1kMedical Imaging and Analysis

2008–2024 · research · R01

3-D Visualization and Prediction of Vertebral Fractures

Elise F Morgan · Charles River Associates · funded by National Institutes of Health

$52.5kMedical Imaging and Analysis

2008–2025 · research · R01

3-D Visualization and Prediction of Vertebral Fractures

Elise F Morgan · Charles River Associates · funded by National Institutes of Health

$523.3kMedical Imaging and Analysis

2008–2020 · research · R01

Molecular Mechanisms of Homeostatic Synaptic Plasticity

Hengye Man · Charles River Associates · funded by National Institutes of Health

$409.3kNeuroscience and Neuropharmacology Research

2008–2025 · research · R01

3-D Visualization and Prediction of Vertebral Fractures

Elise F Morgan · Charles River Associates · funded by National Institutes of Health

$35k

2006–2021 · research · R01

Sequencing and Initiation in Speech Production

Frank H Guenther · Charles River Associates · funded by National Institutes of Health

$349.8kStuttering Research and Treatment

2006–2026 · research · R01

Sequencing and Initiation in Speech Production

Frank H Guenther · Charles River Associates · funded by National Institutes of Health

$611.2kStuttering Research and Treatment

2006–2026 · research · R01

Sequencing and Initiation in Speech Production

Frank H Guenther · Charles River Associates · funded by National Institutes of Health

$632.3kStuttering Research and Treatment

2006–2026 · research · R01

Sequencing and Initiation in Speech Production

Frank H Guenther · Charles River Associates · funded by National Institutes of Health

$632kStuttering Research and Treatment

2006–2021 · research · R01

Sequencing and Initiation in Speech Production

Frank H Guenther · Charles River Associates · funded by National Institutes of Health

$349.6kStuttering Research and Treatment

2006–2020 · training · T32

Translational Research in Biomaterials

Mark W. Grinstaff · Charles River Associates · funded by National Institutes of Health

$287.3kBiomedical and Engineering Education

2006–2020 · training · T32

Translational Research in Biomaterials

Mark W. Grinstaff · Charles River Associates · funded by National Institutes of Health

$292.1kBiomedical and Engineering Education

2006–2020 · training · T32

Translational Research in Biomaterials

Mark W. Grinstaff · Charles River Associates · funded by National Institutes of Health

$95.8kBiomedical and Engineering Education

2006–2026 · research · R01

Sequencing and Initiation in Speech Production

Frank H Guenther · Charles River Associates · funded by National Institutes of Health

$649.1kStuttering Research and Treatment

2006–2021 · research · R01

Sequencing and Initiation in Speech Production

Frank H Guenther · Charles River Associates · funded by National Institutes of Health

$361.1kStuttering Research and Treatment

2006–2026 · research · R01

Sequencing and Initiation in Speech Production

Frank H Guenther · Charles River Associates · funded by National Institutes of Health

$592.5k

2005–2022 · research · R01

Interdisciplinary Study of Two Novel Anticonvulsants in Alcoholism

Todd J. Farchione · Charles River Associates · funded by National Institutes of Health

$736k

2005–2021 · research · R01

Sequencing and Initiation in Speech Production

Frank H Guenther · Charles River Associates · funded by National Institutes of Health

$349.9kStuttering Research and Treatment

2005–2021 · research · R01

Interdisciplinary Study of Two Novel Anticonvulsants in Alcoholism

Todd J. Farchione · Charles River Associates · funded by National Institutes of Health

$30k

2005–2021 · research · R01

Interdisciplinary Study of Two Novel Anticonvulsants in Alcoholism

Todd J. Farchione · Charles River Associates · funded by National Institutes of Health

$740.4k

2005–2021 · research · R01

Sequencing and Initiation in Speech Production

Frank H Guenther · Charles River Associates · funded by National Institutes of Health

$349.9kStuttering Research and Treatment

2001–2022 · training · T32

Training Program in Quantitative Biology and Physiology

John A. White · Charles River Associates · funded by National Institutes of Health

$381.3k

2001–2022 · training · T32

Training Program in Quantitative Biology and Physiology

John A. White · Charles River Associates · funded by National Institutes of Health

$385.6k